Berlin - Delayed Quote • EUR
Brainstorm Cell Therapeutics Inc (GHDN.BE)
At close: April 25 at 9:00 PM GMT+2
Loading Chart for GHDN.BE
DELL
- Previous Close
0.5000 - Open
0.4910 - Bid 0.4520 x --
- Ask 0.5360 x --
- Day's Range
0.4920 - 0.5120 - 52 Week Range
0.1310 - 3.1200 - Volume
1,000 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: GHDN.BE
Performance Overview: GHDN.BE
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
GHDN.BE
110.59%
S&P 500
5.84%
1-Year Return
GHDN.BE
81.73%
S&P 500
22.03%
3-Year Return
GHDN.BE
82.38%
S&P 500
20.77%
5-Year Return
GHDN.BE
85.30%
S&P 500
72.46%
Compare To: GHDN.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap undefined -
Industry -
0.0030
0.00%
Mkt Cap EUR 140,208
Industry Biotechnology
Statistics: GHDN.BE
Valuation Measures
As of 4/24/2024
Market Cap
34.80M
Enterprise Value
34.78M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-1.64
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: GHDN.BE
GHDN.BE does not have Company Insights